Table of Contents
What changed
Revenue fell 68.9% to NZ$135.4m from NZ$436.2m as interest and fee income from mortgage lending compressed sharply. The reported loss narrowed 35.8% on both a PBT and NPAT basis (identical because no tax was recognised in either year) to NZ$427.5m from NZ$665.3m. Operating cash inflow collapsed 94.3% to NZ$182.0m from NZ$3.2b, even though closing cash rose 10.0% to NZ$2b. On the balance sheet, total assets fell 21.3% to NZ$2.7b, gross borrowings eased 5.7% to NZ$2.4b, and equity was cut 61.9% to NZ$262.8m, absorbing almost the entire annual loss. No dividend was declared.
What matters
- Revenue base has hollowed out. Interim commentary noted the company "has not deployed its available funds into new loan receivables," and the HY21-to-FY21 shape confirms that: HY21 revenue of NZ$92.9m implies a second-half revenue run of just NZ$42.5m — a further step-down rather than stabilisation.
- Equity cushion is thin relative to borrowings. Equity of NZ$262.8m supports gross borrowings of NZ$2.4b. Another loss of FY21 magnitude would effectively exhaust the equity base, and ROE deteriorated to -162.7% from -96.4%.
- The "improved" loss is a denominator story. Losses narrowed in absolute terms, but against a revenue base that is now less than a third of FY20's, the underlying earnings power has weakened, not strengthened.
Expectations
No numerical targets, forward-work balance, or guidance were provided, so the result cannot be judged against management metrics. On intra-period shape, HY21 contributed 68.6% of full-year revenue and 79.9% of the full-year NPAT loss, meaning H2 revenue fell sharply while the H2 loss moderated to roughly NZ$85.7m. That softer H2 loss is the only quasi-forward signal in the filing, and it is not supported by any stated run-rate or pipeline disclosure.
Quality of result
Low. The narrower loss is not accompanied by cash generation: operating cash fell from NZ$3.2b to NZ$182.0m, cash conversion deteriorated materially, and the positive closing cash movement is more a function of minimal investing activity (capex just NZ$1.0m, down from NZ$10.5m) than operating strength. Pre-lease free cash flow of NZ$181.1m is almost entirely the residue of a shrinking loan book rather than earnings. With no non-recurring adjustments, no non-GAAP reconciliation, and no segment disclosure, there is little in the release that argues the FY21 shape is durable, and the HY21-to-FY21 revenue step-down points the other way.
Unresolved
- What is the credit quality and recoverability profile of the remaining loan receivables, given the decision not to deploy new funds?
- What is the maturity schedule and covenant position on the NZ$2.37b of borrowings against NZ$262.8m of equity?
- What specifically drove the NZ$3.0b swing in operating cash flow — loan book run-off, timing of interest receipts, or borrower behaviour?
- Is the strategy now orderly wind-down or a repositioning, and what funding has actually been secured through the "innovative funding opportunities" referenced?
This briefing cannot assess solvency, loan-book credit quality, or covenant headroom because the supplied data contains no receivables ageing, impairment detail, or debt-maturity disclosure.
Key metrics
| Metric | FY21 | FY20 | Change |
|---|---|---|---|
| Revenue | $135.4m | $436.2m | -68.9% ↓ |
| Net profit after tax | −$427.5m | −$665.3m | +35.8% ↑ |
| Net cash inflow from operating activities | $182m | $3.2b | -94.3% ↓ |
| Profit before tax | −$427.5m | −$665.3m | +35.8% ↑ |
| Cash and cash equivalents | $2b | $1.8b | +10.0% ↑ |
| Total assets | $2.7b | $3.5b | -21.3% ↓ |
Analytical metrics
| Metric | FY21 | FY20 | Context |
|---|---|---|---|
| FCF pre-lease | $181.1m | $3.2b | −$3b |
| FCF post-lease | $181.1m | $3.2b | −$3b |
| FCF / NPAT | 42.4% | 480.7% | complementary conversion metric |
| Capex % revenue | 0.7% | 2.4% | — |
| Capex | −$0.95m | −$10.5m | +$9.6m |
| Net debt | $381.9m | $706.5m | −$324.6m |
| Gross borrowings | $2.4b | $2.5b | −$143.6m |
| ROE (annualised) | -162.7% | -96.4% | Weakening |
| HY21 share of FY21 revenue | 68.6% | — | Other half was 31.4% |
| HY21 share of FY21 NPAT | 79.9% | — | Other half was 20.1% |
| Profit from continuing operations | −$427m | −$665.3m | +$238.3m |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.